Publications by authors named "Charlotte Ahern"

Claim this Profile
A
A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011).
Mignon L Loh, Sarah K Tasian, Karen R Rabin, Patrick Brown, Daniel Magoon, Charlotte H Ahern

Pediatr Blood Cancer· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-species identification of a plasma microRNA signature for detection, therapeutic monitoring, and prognosis in osteosarcoma.
Wendy Allen-Rhoades, Lyazat Kurenbekova, Laura Satterfield, Neha Parikh, Daniel Fuja, Charlotte Ahern

Cancer Med· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of Seneca Valley Virus (NTX-010) in children with relapsed/refractory solid tumors: a report of the Children's Oncology Group.
Michael J Burke, Charlotte Ahern, Brenda J Weigel, John T Poirier, Charles M Rudin

Pediatr Blood Cancer· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial and viral clearance study of reovirus (Reolysin) in children with relapsed or refractory extra-cranial solid tumors: a Children's Oncology Group Phase I Consortium report.
E Anders Kolb, Valerie Sampson, Deborah Stabley, Alexa Walter, Katia Sol-Church, Charlotte Hsieh Ahern

Pediatr Blood Cancer· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I Study of Cixutumumab (IMC-A12) in Combination with Temsirolimus (CCI-779) in Children with Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Report.
Maryam Fouladi, John P Perentesis, Lars M Wagner, Alexander A Vinks, Joel M Reid, Charlotte Ahern

Clin Cancer Res· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of MK-2206 in children with refractory malignancies: a Children's Oncology Group study.
Maryam Fouladi, John P Perentesis, Christine L Phillips, Sarah Leary, Joel M Reid, Charlotte H Ahern

Pediatr Blood Cancer· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: a Children's Oncology Group Study.
Rochelle Bagatell, Robin Norris, Ashish M Ingle, Charlotte Ahern, Stephan Voss

Pediatr Blood Cancer· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of imetelstat in children with refractory or recurrent solid tumors: a Children's Oncology Group Phase I Consortium Study (ADVL1112).
Patrick A Thompson, Rachid Drissi, Jodi A Muscal, Eshini Panditharatna, Maryam Fouladi, Charlotte H Ahern

Clin Cancer Res· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: a Children's Oncology Group phase 1 consortium study.
Trent R Hummel, Lars Wagner, Charlotte Ahern, Maryam Fouladi, Joel M Reid

Pediatr Blood Cancer· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I pharmacokinetic and pharmacodynamic study of pazopanib in children with soft tissue sarcoma and other refractory solid tumors: a children's oncology group phase I consortium report.
Julia L Glade Bender, Alice Lee, Joel M Reid, Sylvain Baruchel, Timothy Roberts, Charlotte H Ahern

J Clin Oncol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcome of centrally located low-grade glioma in children.
Keita Terashima, Kevin Chow, Jeremy Jones, Charlotte Ahern, Eunji Jo

Cancer· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.
Yael P Mossé, Megan S Lim, Stephan D Voss, Keith Wilner, Katherine Ruffner, Charlotte Ahern

Lancet Oncol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: a Children's Oncology Group phase I consortium study (ADVL0916).
Jodi A Muscal, Patrick A Thompson, Terzah M Horton, Ashish M Ingle, Charlotte H Ahern

Pediatr Blood Cancer· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: a Children's Oncology Group Phase I Consortium study.
Yael P Mossé, Emily Lipsitz, Elizabeth Fox, David T Teachey, John M Maris, Charlotte H Ahern

Clin Cancer Res· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial and pharmacokinetic study of aflibercept (VEGF Trap) in children with refractory solid tumors: a children's oncology group phase I consortium report.
Julia Glade Bender, Susan M Blaney, Scott Borinstein, Joel M Reid, Sylvain Baruchel, Charlotte Ahern

Clin Cancer Res· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability and pharmacokinetic profile of a sunitinib powder formulation in pediatric patients with refractory solid tumors: a Children's Oncology Group study.
Steven G DuBois, Suzanne Shusterman, Joel M Reid, Ashish M Ingle, Charlotte H Ahern

Cancer Chemother Pharmacol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology Group.
Suman Malempati, Brenda Weigel, Ashish M Ingle, Charlotte H Ahern, Julie M Carroll

J Clin Oncol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk-specific optimal cancer screening schedules: an application to breast cancer early detection.
Charlotte Hsieh Ahern, Yi Cheng, Yu Shen

Stat Biosci· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obesity does not increase complications following pancreatic surgery.
Courtney J Balentine, Jose Enriquez, Guillermina Cruz, Sally Hodges, Vivek Bansal, Charlotte Ahern

J Surg Res· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I and pharmacokinetic study of sunitinib in pediatric patients with refractory solid tumors: a children's oncology group study.
Steven G Dubois, Suzanne Shusterman, Ashish M Ingle, Charlotte H Ahern, Joel M Reid

Clin Cancer Res· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreatic resection without routine intraperitoneal drainage.
William E Fisher, Sally E Hodges, Eric J Silberfein, Avo Artinyan, Charlotte H Ahern

HPB (Oxford)· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Down-regulation of ZIP4 by RNA interference inhibits pancreatic cancer growth and increases the survival of nude mice with pancreatic cancer xenografts.
Min Li, Yuqing Zhang, Uddalak Bharadwaj, Qihui Jim Zhai, Charlotte H Ahern

Clin Cancer Res· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines.
Charlotte Hsieh Ahern, Yu Shen

Cancer Epidemiol Biomarkers Prev· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis